OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint Corporate Broker and Joint ...

Viralgen and the CTNNB1 Foundation have come together to manufacture an investigational gene therapy designed to treat CTNNB1 ...

With multiple living areas overlooking the pool, contemporary design and seamless in-outdoor flow, this dual level home is ideal for family life and relaxed entertaining. It is ideally located ...